“To understand an epidemic, you often need the 35,000-foot view, looking for trends and patterns.” says Dr. John Brooks. “But you also need to find out what’s going on at ground level, what’s happening to the people at risk of, and being affected by, the condition you’re trying to prevent.” This is how Brooks approaches his work to improve prevention and treatment for HIV-affected people, and how he approached his role in helping the public understand the science behind how to prevent Ebola transmission during the 2014 Ebola response.
Information
Contact CDC Public Affairs 404.639.3286 media@cdc.gov
Joyce MP, Kuhar D, Brooks JT, “Notes from the Field: Occupationally Acquired HIV Infection Among Health Care Workers – United States, 1985-2013.”, Morbidity and Mortality Weekly Report, 63(53):1245-6, 2014
Brooks JT, Buchacz K, Gebo K, and Mermin J, “Aging and HIV Infection: The Public Health Perspective”, American Journal of Public Health, 102(8): 1516-1526, 2012.
Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Segolodi TM, Soud FA, Henderson FL, Pathak SR, Rose CE, Chillag KL, Mutanhaurwa R, Chirwa LI, Kasonde M, Abebe D, Buliva E, Gvetadze RJ, Johnson S, Sukalac T, Thomas VT, Hart C, Johnson JA, Malotte CK, Hendrix CW, and Brooks JT for the TDF2 Study Group, “Safety and Efficacy of Daily Oral Antiretroviral Use for the Prevention of HIV Infection in Heterosexually Active Young Adults in Botswana: the TDF2 Study”, New England Journal of Medicine, 367:423-434, 2012.
Althoff KN, Buchacz K, Hall I, Zhang J, Hanna DB, Rebeiro P, Gange SJ, Moore RD, Kitahata MM, Gebo KA, Martin J, Justice AC, Horberg M, Hogg RS, Sterling TR, Cescon A, Klein MB, Thorne J, Crane H, Mugavero1 MJ, Napravnik S, Rodriguez B, Kirk GD, Anastos K, Jacobson LP, and Brooks JT for The North American AIDS Cohort Collaboration on Research and Design, “Trends in antiretroviral therapy use, HIV RNA plasma viral loads and CD4 T-lymphocyte counts among human immunodeficiency virus (HIV)-infected persons in care in the United States, 2000-2008”, Annals of Internal Medicine, 157(5):325-335, 2012.
Brooks JT, Kaplan JE, Holmes KK, Benson C, Pau A, Masur H, “HIV-associated opportunistic infections: going, going but not gone. The continued need for prevention and treatment guidelines”, Clinical Infectious Diseases, 48(5):609-11, 2009.
Brooks JT, Sowers EG, Wells JG, Greene KD, Griffin PM, Hoekstra RM, Strockbine NA, “Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002”, Journal of Infectious Diseases, 192(8): 1422-9, 2005.
